Schedule 13G ownership disclosure

Monopar Therapeutics Inc

Security class unavailable · CUSIP: 61023L207

Event date: 2024-10-24

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-24-017900
Form type
SC 13G
Filer
Monopar Therapeutics
CIK
CIK 1645469
Filed
Oct 24, 2024
Reporting period
Oct 24, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub